Pioneer Healthcare Partners
VC Fund
Raleigh, United States
Pioneer Healthcare Partners is a VC fund in Raleigh focused on Health Care and Medical Device. Pioneer Healthcare Partners, LP (“PHP”) is the private equity arm of Pioneer Group Holdings, LLC (“Pioneer”) the investment office for the Parkinson Family. Pioneer was founded in 2018, by Robert L. Parkinson Jr., the former Chairman and CEO of Baxter International. PHP has a specific focus on investing in industries such as Healthcare, Education,Real Estate and Agriculture.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Pioneer Healthcare Partners invests in
Stages Pioneer Healthcare Partners invests in
Countries Pioneer Healthcare Partners invests in
Investment Focus
Industry
- Health Care 8 (67%)
- Medical Device 6 (50%)
- Medical 4 (33%)
- Biotechnology 4 (33%)
- Sensor 1 (8%)
Stage
- Series B 4 (33%)
- Seed 3 (25%)
- Series A 2 (17%)
- Series C 2 (17%)
- Series D 1 (8%)
Country
- United States 9 (75%)
- Israel 1 (8%)
- United Kingdom 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Partum Health
|
Partum Health offers the best of online and offline specialty care for women and families. Patient engagement takes place via HIPAA compliant messaging, through digital care programs, telehealth visits as well as in person care, both in home and in office. Families receive coordinated care across mental health, physical therapy, lactation andinfant feeding support, nutrition, acupuncture or working with a birth doula or postpartum doula. Partum's model is designed to prevent and treat the most common complications of fertility, pregnancy, postpartum and early family life. | $3.1M / Seed / Sep 22, 2023 | |
Kinnos
|
Kinnos is a biotechnology company pioneering color technology to revolutionize how they use disinfectants. The company's first product, Highlight, is a point-of-use additive that greatly improves visibility and end-user compliance of disinfectants. Their goal is to empower people to disinfect surfaces with confidence and to provide societywith peace of mind through disinfection they can see. | $15M / Series B / May 02, 2023 | |
Piccolo Medical
|
Piccolo Medical is a medical device . | Series A / Mar 01, 2022 | |
Surgical Innovation Associates
|
Surgical Innovation Associates, Inc. (“SIA”, sia.health) is a commercial stage medical device company, committed to raising the standard of care in plastic, reconstructive, and general surgery and lowering systemic costs through “for surgeon, by surgeon” implantable device innovation. Headquartered in downtown Chicago, Illinois, SIA’s proximity toacademia and world-leading healthcare institutions has created the ideal ecosystem for the translation of concepts into devices to meet key clinical needs. The company’s flagship product family, DuraSorb® Monofilament Mesh is on the market and indicated for use in reinforcement of soft tissues where weakness exists. DuraSorb® was specifically designed for plastic, reconstructive, and general surgery and is US FDA 510(k) cleared and CE marked. The product is available in multiple sizes, and is part of a growing pipeline of novel medical devices made from commonly-used resorbable polymers. | $15M / Series B / Dec 16, 2021 | |
Cellevolve
|
Cellevolve Bio is a development and commercialization company focused on cell therapies. | $6M / Seed / Nov 18, 2021 | |
Innoblative Designs
|
Innoblative is developing Sira™, a Saline-assisted Intraoperative Radiofrequency Ablation device that uses bipolar current to intraoperatively create a controlled zone of ablation. Sira’s unique design and saline microinfusion system allow it to have unparalleled contact with target tissue and to be powered with existing electrosurgical generatorsalready installed in the operating room. This device represents an exciting new option for intraoperative ablation of soft tissue which surgeons can easily adopt. | Seed / Oct 01, 2021 | |
Signifier Medical Technologies
|
Snoozeal was founded in 2015 in United Kingdom. Co-founder Prof. Dr Anshul Sama, working in a multidisciplinary sleep team, was deeply empathic with many of his patients that were struggling with conventional treatment options that had failed to change in the last two decades. Not dissimilar to practice in many parts of conventional medicine, theemphasis was on treatment of the end result (i.e. splinting the airway open) rather than treating the root cause- collapse of airway due to excessive loss of muscle tone. Over the years Prof Sama came across many devices, all of which had to be worn during sleep, were invariably uncomfortable, only effective when in use and further disrupted the already poor sleep quality. | $35M / Series D / Jul 27, 2021 | |
Truvian Sciences
|
Truvian disrupts the blood-testing industry by developing an automated, benchtop diagnostic system to provide lab-accurate results.The blood-testing system combines chemistry, immunoassays, and hematology assays in one device. With its 20-minute, single-run wellness panel that requires only several drops of blood, the company aims to cover about40 commonly ordered diagnostic tests, including a lipid panel, metabolic panel, and complete blood cell count. Its dry reagent and optical sensing technologies, which require no refrigeration, can perform a complete blood count, basic metabolic and lipid panel, hemoglobin and glucose tests, thyroid screenings, and liver and kidney function exams. The company also offers Easy Check, a blood-based serologic test Truvian claims can detect the presence of the antibodies effective against SARS-CoV-2, the virus that causes COVID-19.Dena Marrinucci, Kim Kamdar, Mark Bowles, and Pieter van Rooyen established the San Diego, California-based company in 2015. | $105M / Series C / Feb 24, 2021 | |
3NT Medical
|
3NT is disrupting Ear, Nose and Throat surgery by introducing novel single-use endoscopes purpose-built for ENT specialists. | Series C / Sep 14, 2020 | |
|
Kinnos
|
Kinnos is a biotechnology company pioneering color technology to revolutionize how they use disinfectants. The company's first product, Highlight, is a point-of-use additive that greatly improves visibility and end-user compliance of disinfectants. Their goal is to empower people to disinfect surfaces with confidence and to provide societywith peace of mind through disinfection they can see. | $6M / Series A / Mar 05, 2020 | |
| See all 12 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Pioneer Healthcare Partners invest in?
Pioneer Healthcare Partners invests primarily in Health Care, Medical Device and Medical startups, most often at Series B and Seed stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Pioneer Healthcare Partners last invest?
The most recent investment recorded for Pioneer Healthcare Partners closed in Sep 2023. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
